Vitiligo Drugs Market, by Drug Class (Calcineurin Inhibitors, Corticosteroids, Immunomodulator, and Psoralens), by Route of Administration (Oral and Topical), by Distribution Channel (Hospital Pharmacy, Dermatology Clinic, Retail Pharmacy, and Online Pharmacy), and by Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis 2018 – 2026

  • To Be Published : Feb 2019 |
  • Format : CMI Insight PPT Format CMI Insight PDF Format

Vitiligo is a skin condition characterized by white patches on the skin. It is also known as skin depigmentation. In skin depigmentation, the skin's pigment-making cells known as melanocytes are lost or destroyed, which result into patches. The patches of affected skin appear white and usually have sharp margins. In most of the cases, the patches emerge on the skin, which is more exposed to sunlight. Although the disease can occur at any age, it is more observed in the mid-twenties. Although the disease does not affect the physical health of a person, it creates concerns about physical appearance and ethical identity of the person. The exact cause of Vitiligo is not known. It is mostly observed in people with family history of autoimmune disease. Vitiligo is classified into two types: segmental and non-segmental. In segmental vitiligo, only one side of body is affected by skin depigmentation. In non-segmental vitiligo, both sides of body are affected by skin depigmentation and the affected area of the skin expands with time. In general, non-segmental vitiligo is more common than segmental vitiligo.

Vitiligo Drugs Market Drivers

Vitiligo drugs market is expected to witness significant growth, owing to development of new therapies for vitiligo. For instance, in Feb 2018, researchers at Yale University School of Medicine discovered a new therapy for the treatment of vitiligo. The therapy can aid in returning the color of depigmented skin due to vitiligo. The new combination therapy includes oral medication of Xeljanz (tofacitinib) and ultraviolet-B light therapy. Xeljanz is used in the treatment of rheumatoid arthritis and ultraviolet B (UVB) light therapy is an effective treatment for psoriasis. UVB penetrates the skin and slows the growth of affected skin cells.

Moreover, increasing pipeline studies to develop new drugs for the treatment of vitiligo is expected to drive vitiligo drugs market growth. For instance, in December 2016, Nicolaus Copernicus University initiated the phase 1 and phase 2 clinical trial for Atorvastatin calcium salt and Simvastatin-acid sodium salt. The study has been initiated for the evaluation of vitiligous lesions repigmentation after the administration of Atorvastatin calcium salt and Simvastatin-acid sodium salt in patients with active vitiligo. The study is estimated to complete by April 2019.

However, adoption of unlicensed medication may restraint the vitiligo drugs market growth. Topical Calcineurin inhibitors (Tacrolimus and Pimecrolimus) used for treating vitiligo are unlicensed medicines. Prescription of unlicensed medicines for the treatment of vitiligo is attributed to the assumption that these medicine are more effective and offer some benefits in the treatment and show lesser side effect unlike corticosteroids that cause thinning of the skin.

Vitiligo Drugs Market- Regional Analysis

On the basis of region, the global vitiligo drugs market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

Increasing prevalence of vitiligo in North America is expected to boost the vitiligo drug market growth during the forecast period. For instance, according to American Academy of Dermatology, in November 2013, over 150,000 people in the U.S. across all age were treated for vitiligo. The overall cost incurred was over US$ 328 per patient and total medical cost was valued at US$ 49 million.

Asia Pacific is expected to witness significant growth in the vitiligo drugs market, owing to presence of major players in this region and launch of new products. For instance, in 2014, Dr. Reddy’s Laboratories, an India-based multinational pharmaceutical company, launched Melgain lotion to treat vitiligo in partnership with Issar Pharmaceuticals Pvt Ltd. Under the partnership, Issar Pharmaceuticals was tasked to manufacture the product and Dr. Reddy’s Laboratories for its commercialization.

Key players operating in the global vitiligo drugs market include, AXIM Biotechnologies, Dr. Reddy’s Laboratories, Boston Pharmaceutical, Castle Creek Pharma, Dermavant Sciences, JN Biosciences, Bristol-Myers Squibb, Incyte Corporation, Clinuvel Pharmaceuticals, Glenmark Pharmaceuticals, and Galderma laboratories (Nestlé Skin Health).

Vitiligo Drugs Market - Taxonomy

By Drugs Class

  • Calcineurin Inhibitors
  • Corticosteroids
  • Immunomodulator
  • Psoralens

By Route of Administration

  • Oral
  • Topical

By Distribution Channel

  • Hospital Pharmacy
  • Dermatology Clinic
  • Retail Pharmacy
  • Online Pharmacy

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa

Research Methodology

Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:

  • Primary Research (Trade Surveys and Experts Interviews)
  • Desk Research
  • Proprietor Data Analytics Model

In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.


Smiley face

Coherent Market Insights desk research is based on a principle set of research techniques:

  • National level desk research: It Includes research analysis of regional players, regional regulatory bodies, regional trade associations, and regional organization.
  • Multinational level desk research: The research team keeps a track of multinational players, global regulatory bodies, global trade associations, and global organization.

Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:

  • Governmental bodies, National and international social welfare institutions, and organizations creating economic policies among others.
  • Trade association, National and international media and trade press.
  • Company Annual reports, SEC filings, Corporate Presentations, press release, news, and specification sheet of manufacturers, system integrators, brick and mortar - distributors and retailers, and third party online commerce players.
  • Scientific journals, and other technical magazines and whitepapers.
Smiley face

Preliminary Data Mining

The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.

Data Standardization:

Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.

Coherent Statistical model

We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:

  • Micro-economic indicators
  • Macro-economic indicators
  • Environmental indicators
  • Socio-political indicators
  • Technology indicators

Data Processing

Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.

Data Validation

This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:

  • It provides first-hand information on the market dynamics, outlook, and growth parameters.
  • Industry experts validates the estimates which helps the company to cement the on-going research study.
  • Primary research includes online surveys, face-to face interviews, and telephonic interviews.

The primary research is conducted with the ecosystem players including, but not limited to:

  • Raw Material Suppliers
  • Manufacturers
  • System Integrators
  • Distributors
  • End-users

Choose License Type

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

[email protected]

Key Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.